RecallDepth
Class II Terminated

Fexofenadine HCl Tablets, USP, 180 mg, packaged in a) 30-count bottles (NDC 0378-0782-93) and b) 500-count bottles (NDC 0378-0782-05); Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA.

Company
Mylan Pharmaceuticals Inc.
Recall Initiated
January 18, 2019
Posted
February 6, 2019
Recall Number
D-0428-2019
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
88,090 bottles
Firm Location
Morgantown, WV, United States

Reason for Recall

Failed Impurities/Degradation Specifications: Related compound results obtained during routine stability testing was slightly elevated above specification.

Distribution

Nationwide in the USA

Lot / Code Info

Lot #: a) 3085490, 3085491, Exp 04/19; b) 3085492, 3085493, 3085494, 3085495, 3085496, Exp 04/19

More recalls by Mylan Pharmaceuticals Inc.

View all recalls by this company →

Other recent Class II Drug recalls